GlassScriptPhysician profile
Lan K Nguyen
NPI 1477632586
$4,169.75
in general payments reported to CMS, 2019-2025
25 companies · $769 in 2025
The $769 reported for 2025 was more than what 85% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $465 · 2021: $665 · 2022: $530 · 2023: $810 · 2024: $635 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,213.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,030.83 | 2019-2022 | |
| Biotronik Nro, INC. | $426.86 | 2025 | Prospera |
| Astrazeneca Pharmaceuticals LP | $395.70 | 2022-2025 | Fasenra, Farxiga |
| Si-Bone, INC. | $347.22 | 2022-2025 | |
| Gilead Sciences, INC. | $221.75 | 2020-2024 | |
| Spinal Simplicity, LLC | $204.17 | 2023 | Ha Minuteman G3-R |
| Ibsa Pharma INC. | $191.92 | 2022-2024 | Tirosint, Licart, Licart |
| Nevro Corp. | $146.37 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $124.72 | 2023 | Dupixent |
| Globus Medical, INC. | $124.47 | 2024 | Excelsius3d Imaging System |
| Incyte Corporation | $123.83 | 2025 | Opzelura |
| Glaxosmithkline, LLC. | $118.85 | 2023 | Arexvy |
| Abbott Laboratories | $118.27 | 2024 | Freestyle Libre 3 |
| Spr Therapeutics, INC | $113.93 | 2024 | Sprint Pns System |
| Zimmer Biomet Holdings, INC. | $109.94 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vgi Medical, LLC | $70.78 | 2021 | |
| Abbvie INC. | $70.00 | 2025 | |
| Foundation Medicine, INC. | $68.87 | 2020-2021 | |
| Deciphera Pharmaceuticals INC. | $40.88 | 2021 | |
| Amgen INC. | $36.61 | 2020-2024 | Krystexxa |
| Genesys Orthopedics Systems, L.L.C. | $25.00 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.04 | 2023 | Quviviq |
| Relievant Medsystems, INC. | $15.64 | 2021 | |
| Inspire Medical Systems, INC. | $14.51 | 2024 | Inspire |
| Assertio Therapeutics, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lan Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.